Heparin

von Willebrand factor ; Homo sapiens







66 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33278841 The heparin-von Willebrand factor interaction and conventional tests of haemostasis - the challenges in predicting bleeding in cardiopulmonary bypass. 2021 Mar 1
2 32496552 DNA binds to a specific site of the adhesive blood-protein von Willebrand factor guided by electrostatic interactions. 2020 Jul 27 1
3 28898897 von Willebrand Factor and Venous Thromboembolism: Pathogenic Link and Therapeutic Implications. 2018 Apr 1
4 28279966 Plasmin Cleaves Von Willebrand Factor at K1491-R1492 in the A1-A2 Linker Region in a Shear- and Glycan-Dependent Manner In Vitro. 2017 May 1
5 25969127 Bone Marrow-Derived Mesenchymal Stem Cells Have Innate Procoagulant Activity and Cause Microvascular Obstruction Following Intracoronary Delivery: Amelioration by Antithrombin Therapy. 2015 Sep 1
6 24790143 von Willebrand factor directly interacts with DNA from neutrophil extracellular traps. 2014 Jul 1
7 23069711 The blood and vascular cell compatibility of heparin-modified ePTFE vascular grafts. 2013 Jan 1
8 23907946 Effect of unfractionated heparin, enoxaparin and sulodexide on the relations between secretion and expression of OPG, RANKL and vWF in HUVEC. 2013 2
9 20505748 The mechanism of melanoma-associated thrombin activity and von Willebrand factor release from endothelial cells. 2010 Sep 1
10 17977030 Evidence from limited proteolysis of a ristocetin-induced conformational change in human von Willebrand factor that promotes its binding to platelet glycoprotein Ib-IX-V. 2008 May-Jun 3
11 16338223 Identification of amino acid residues essential for heparin binding by the A1 domain of human von Willebrand factor. 2006 Jan 27 5
12 15670034 A potential pharmacogenomic strategy for anticoagulant treatment in non-ST elevation acute coronary syndromes: the role of interleukin-1 receptor antagonist genotype. 2005 Feb 1
13 16158039 Elevation of plasma von Willebrand factor and tumor necrosis factor-a in obese subjects and their reduction by the low molecular weight heparin tinzaparin. 2005 Sep 1
14 15249683 Binding of platelet glycoprotein Ibalpha to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS13. 2004 Jul 20 1
15 15358546 Binding of von Willebrand factor to the small proteoglycan decorin. 2004 Sep 10 1
16 12686329 Comparison of effects on markers of blood cell activation of enoxaparin, dalteparin, and unfractionated heparin in patients with unstable angina pectoris or non-ST-segment elevation acute myocardial infarction (the ARMADA study). 2003 Apr 15 1
17 12801846 Effect of unfractionated heparin and a low molecular weight heparin (enoxaparin) on coagulant activity of cultured human endothelial cells. 2003 Jun 1
18 12851529 Control of von Willebrand factor multimer size by a fibronectin-related substance. 2003 Jul 1
19 12871332 Sulfatides inhibit platelet adhesion to von Willebrand factor in flowing blood. 2003 Jun 1
20 11853892 A von Willebrand factor-derived heparin-binding peptide regulates cell--substrate adhesive strength and chemokinesis behavior. 2002 Jan 30 3
21 11992238 Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factor. 2002 Apr 1
22 12022870 Two clusters of charged residues located in the electropositive face of the von Willebrand factor A1 domain are essential for heparin binding. 2002 May 28 1
23 11254909 Effects of heparin and aspirin on circulating P-selectin, E-selectin and von Willebrand Factor levels in healthy men. 2001 Apr 2
24 11427638 Endothelial dysfunction marker von Willebrand factor antigen in haemodialysis patients: associations with pre-dialysis blood pressure and the acute phase response. 2001 Jul 1
25 11535495 Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. 2001 Sep 15 1
26 11776314 Defect of heparin binding in plasma and recombinant von Willebrand factor with type 2 von Willebrand disease mutations. 2001 Dec 2
27 10739395 Protamine sulphate inhibits platelet membrane glycoprotein Ib-von Willebrand factor activity. 2000 Feb 1
28 11920189 von Willebrand factor binding to heparin in various types of von Willebrand disease. 2000 8
29 10089894 Selectivity of von Willebrand factor triplet bands towards heparin binding supports structural model. 1999 Mar 8
30 10590063 Modulation by heparin of the interaction of the A1 domain of Von Willebrand factor with glycoprotein Ib. 1999 Dec 15 4
31 21340993 Screening for Candidate Mutations Causing von Willebrand's Disease (vWD). 1999 1
32 9490688 Molecular modeling of ligand and mutation sites of the type A domains of human von Willebrand factor and their relevance to von Willebrand's disease. 1998 Mar 15 2
33 9711933 Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease: beneficial effects of enoxaparin. French Investigators of the ESSENCE Trial. 1998 Jul 28 2
34 10743240 [Prethrombotic state in patients with chronic obstructive pulmonary disease and treatment with heparin]. 1998 Dec 1
35 9447247 Biochemical and functional characterization of recombinant von Willebrand factor produced on a large scale. 1997 Dec 1
36 8598091 Heparins designed to specifically inhibit platelet interactions with von Willebrand factor. 1996 Mar 1 14
37 8747526 Platelet adhesion at high shear rates: the roles of von Willebrand factor/GPIb and the beta 1 integrin alpha 2 beta 1. 1996 Jan 1 1
38 8873615 Analysis of the structure and function of the von Willebrand factor A1 domain using targeted deletions and alanine-scanning mutagenesis. 1996 Oct 15 2
39 8885147 Effect of multimerization of human and recombinant von Willebrand factor on platelet aggregation, binding to collagen and binding of coagulation factor VIII. 1996 Oct 1 3
40 7495084 Cultured endothelial cells regulate platelet adhesion to their extracellular matrix by regulating its von Willebrand factor content. 1995 Apr 1
41 7540413 A monoclonal antibody (B724) to von Willebrand factor recognizing an epitope within the A1 disulphide loop (Cys509-Cys695) discriminates between type 2A and type 2B von Willebrand disease. 1995 May 2
42 21043709 Inhibition of Binding of von Willebrand Factor to the Platelet Glycoprotein Ib-IX Complex, Heparin and Sulfatides by Polyanionic Compounds. The Mechanism of Modulation of the Adhesive Function of von Willebrand Factor. 1995 18
43 7819071 Purification and characterization of human platelet von Willebrand factor. 1994 Nov 2
44 7900084 Heparin enhances endothelial cell von Willebrand factor content by growth factor dependent mechanisms. 1994 Nov 5
45 7974349 Epitope mapping of inhibitory monoclonal antibodies to human von Willebrand factor by using recombinant cDNA libraries. 1994 Jun 1
46 8165633 Binding of heparin fractions to von Willebrand factor: effect of molecular weight and affinity for antithrombin III. 1994 Jan 6
47 8276857 Inhibition by heparin of thrombin-catalyzed activation of the factor VIII-von Willebrand factor complex. 1994 Jan 7 5
48 8215459 Heparin-von Willebrand factor binding as assessed by isothermal titration calorimetry and by affinity fractionation of heparins using synthetic peptides. 1993 Nov 1 7
49 8320843 [Biosynthesis in the vascular endothelial cells, molecular structure and function of von Willebrand factor]. 1993 Jun 1
50 8322266 Heparin binding assay of von Willebrand factor (vWF) in plasma milieu--evidence of the importance of the multimerization degree of vWF. 1993 May 3 7